Market Exclusive

CVS HEALTH CORPORATION (NYSE:CVS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

CVS HEALTH CORPORATION (NYSE:CVS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.

(c) On March 2, 2017, CVS Health Corporation (the Company)
appointed Jonathan C. Roberts as Executive Vice President and
Chief Operating Officer of the Company, a newly created position
within the Company. Mr. Roberts, 61, has most recently served as
Executive Vice President of the Company and President of CVS
Caremark, the Companys pharmacy services segment, since September
2012. He was Executive Vice President of the Company and Chief
Operating Officer of CVS Caremark from October 2010 to August
2012. From January 2009 to October 2010, Mr. Roberts served as
Executive Vice President of Rx Purchasing, Pricing and Network
Relations of the Company. Prior to that, Mr. Roberts served as
Senior Vice President and Chief Information Officer of the
Company from January 2006 to January 2009.
As Executive Vice President and Chief Operating Officer, Mr.
Roberts will receive an annual base salary of $1,050,000.
Additionally, Mr. Roberts will continue to participate in the
Companys (i) annual cash incentive plan, (ii) long-term incentive
plan and (iii) annual equity award plan, consisting of both stock
options and restricted stock units, in accordance with the
Companys practices for senior executives generally.
Mr. Roberts has no family relationships with any of the Companys
directors or executive officers, and he has no direct or indirect
material interest in any transaction required to be disclosed to
Item 404(a) of Regulation S-K promulgated under the Securities
Exchange Act of 1934, as amended.
A copy of the press release announcing the above is attached as
Exhibit 99.1 to this Current Report on Form 8-K.
Item 9. Financial Statements and Exhibits
Item 9.01. Financial Statements
(d) Exhibits
Exhibit No.
Description
99.1
Press Release, dated March 2, 2017, of CVS Health
Corporation.

About CVS HEALTH CORPORATION (NYSE:CVS)
CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions. The Retail Pharmacy segment includes retail drugstores, online retail pharmacy Websites and its retail healthcare clinics. CVS HEALTH CORPORATION (NYSE:CVS) Recent Trading Information
CVS HEALTH CORPORATION (NYSE:CVS) closed its last trading session up +0.65 at 81.35 with 5,742,650 shares trading hands.

Exit mobile version